Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soybean Phosphatides and Blood Lipids of Primates <sup>1</sup>.

Journal of food protection·2019
Same author

Reduction and Increase in Thermal Conductivity of Si Irradiated with Ga<sup>+</sup> via Focused Ion Beam.

ACS applied materials & interfaces·2018
Same author

Post-operative pain relief using local infiltration analgesia during open abdominal hysterectomy: a randomized, double-blind study.

Acta anaesthesiologica Scandinavica·2017
Same author

Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood.

Platelets·2006
Same author

Abnormal pulmonary granuloma formation in osteopontin-deficient mice.

American journal of respiratory and critical care medicine·2001
Same author

Macrolide antibiotics and pulmonary inflammation.

FEMS microbiology letters·2001

Related Experiment Video

Updated: Jul 8, 2026

A Complete Method for Evaluating the Performance of Photocatalysts for the Degradation of Antibiotics in Environmental Remediation
08:30

A Complete Method for Evaluating the Performance of Photocatalysts for the Degradation of Antibiotics in Environmental Remediation

Published on: October 6, 2022

Tetracyclines and pulmonary inflammation.

S Rempe1, J M Hayden, R A Robbins

  • 1Carl T. Hayden VA Medical Center, Research (RS/151), Building 27, 650 East Indian School Road, Phoenix, AZ 85012, USA.

Endocrine, Metabolic & Immune Disorders Drug Targets
|January 29, 2008
PubMed
Summary
This summary is machine-generated.

Tetracyclines, known for antibacterial effects, also possess anti-inflammatory properties beneficial for chronic diseases. This review explores their potential in managing pulmonary inflammation and related conditions.

More Related Videos

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
09:56

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Published on: March 2, 2016

Related Experiment Videos

Last Updated: Jul 8, 2026

A Complete Method for Evaluating the Performance of Photocatalysts for the Degradation of Antibiotics in Environmental Remediation
08:30

A Complete Method for Evaluating the Performance of Photocatalysts for the Degradation of Antibiotics in Environmental Remediation

Published on: October 6, 2022

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
09:56

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Published on: March 2, 2016

Area of Science:

  • Pharmacology
  • Immunology
  • Respiratory Medicine

Background:

  • Tetracyclines are broad-spectrum antibiotics interfering with bacterial protein synthesis.
  • These compounds exhibit significant anti-inflammatory properties beyond their antibacterial activity.
  • Tetracyclines are recognized for treating various chronic inflammatory conditions, including autoimmune diseases and neurodegenerative disorders.

Purpose of the Study:

  • To review recent research on tetracycline derivatives' role in controlling pulmonary inflammation.
  • To highlight the mechanisms by which tetracyclines modulate inflammatory responses in the airways.
  • To discuss the therapeutic potential of tetracycline-type drugs in chronic airway diseases.

Main Methods:

  • Literature review of recent findings on tetracyclines and inflammation.
  • Analysis of physiological, cellular, and molecular mechanisms of inflammatory control.
  • Summary of clinical applications and research in pulmonary inflammation.

Main Results:

  • Tetracyclines demonstrate efficacy in managing inflammatory conditions like periodontitis, rosacea, and rheumatoid arthritis.
  • These drugs show promise in treating chronic inflammatory airway diseases such as asthma, bronchiectasis, and cystic fibrosis.
  • Understanding of molecular pathways involved in tetracycline-mediated anti-inflammatory effects has advanced.

Conclusions:

  • Tetracycline derivatives offer a therapeutic avenue for chronic inflammatory diseases, particularly in the pulmonary system.
  • Further research into the anti-inflammatory mechanisms of tetracyclines can lead to novel treatment strategies.
  • The clinical interest in using tetracycline-type drugs for chronic airway inflammation is growing, supported by emerging scientific evidence.